Therapeutic & Specialty Expertise
Neither should your clinical development strategy. That’s why IQVIA's Therapeutic and Specialty Centers of Excellence combines therapeutic expertise, regulatory strategy intelligence, evidence generation, predictive analytics, and global clinical experience to help address the unique challenges of each therapeutic area with greater precision and foresight.
Every disease area presents distinct scientific, clinical, operational, and regulatory challenges. Success requires more than broad development experience. It requires specialized expertise grounded in a deep understanding of disease biology, treatment landscapes, patient populations, and evolving standards of care.
IQVIA's Therapeutic and Specialty Centers of Excellence bring together experts across 18 therapeutic and specialty areas to help develop strategies tailored to the unique needs of each program. By combining therapeutic insight with experience across all phases of development, IQVIA helps make better decisions earlier, avoid common clinical development pitfalls, and position assets for success.
Pressure to bring therapies to market faster is climbing. At the same time, managing development risk, regulatory complexity, and budget constraints continue. Success requires more than a service provider. It requires a partner with the experience, scale, and expertise to guide critical clinical development decisions.
IQVIA is a strategic development partner, bringing together therapeutic expertise, regulatory strategy, evidence generation, operational excellence, and global clinical experience. Through every stage of drug development, navigate uncertainty, overcome obstacles, and advance programs with greater clarity and confidence.
Regulatory requirements evolve as therapies become more complex, study designs become more innovative, and evidence expectations expand beyond approval to demonstrate value. Anticipating regulatory considerations earlier in clinical development helps avoid costly delays, rework, and reduce uncertainty.
IQVIA integrates regulatory intelligence directly into development planning, proactively identify risks, understanding emerging trends, and align clinical and evidence strategies with evolving regulatory expectations. Make decisions earlier with greater clarity, confidence, and preparedness.
Today’s drug development environment demands more evidence than ever before. Data and insights are needed not only regulatory approval, but also differentiation, market access, reimbursement, and long-term value demonstration.
IQVIA helps develop integrated evidence strategies that connect clinical, operational, and real-world evidence across the product lifecycle. By bringing together therapeutic expertise, data assets, and advanced analytics, IQVIA helps answer critical questions earlier.
As drug development costs increase and timelines face growing pressure, waiting to address challenges as they arise is unwise. The future of clinical development depends on anticipating risks, identifying opportunities earlier, and making proactive decisions informed by data and experience.
By combining therapeutic expertise, regulatory strategy intelligence, evidence generation, advanced analytics, and global clinical experience, IQVIA helps identify scientific, operational, and regulatory risks before they impact development outcomes. This predictive approach improves development efficiency, reduces uncertainty, and increases the probability of success.
From common chronic conditions to rare diseases and emerging therapeutic modalities, IQVIA has helped advance some of the industry's most significant medical innovations. Our experience supporting the development of more than 70% of FDA-approved drugs since 2016 and more than 80% of EMA-approved drugs since 2020 provides a unique perspective on what drives development success.
By combining this experience with deep therapeutic specialization, IQVIA applies best practices while tailoring strategies to the unique needs of each drug development program.
Decisions that shape clinical development success often begin with asking the right questions. From early development strategy through launch and real-world evidence generation, deep therapeutic expertise helps anticipate what comes next, challenge assumptions, and identify opportunities and risks before they affect development.
Innovation is reshaping healthcare, but increasingly complex science demands increasingly specialized expertise. With over fifteen Therapeutic and Specialty Centers of Excellence, IQVIA is a trusted partner in clinical development turning scientific innovation into therapeutic breakthroughs for patient impact.
of all FDA-approved drugs between 2016-2025
of all EMA drugs between 2020-2025
IQVIA Institute Report
Advancing innovation in a changing landscape
Related solutions
Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
.svg){kind=icon}
